Aquestive Therapeutics, Inc. Loans Payable, Noncurrent
Aquestive Therapeutics, Inc. (AQST) had Loans Payable, Noncurrent of $34.55 million as of 2023-09-30, per its 10-Q filed 2023-11-06.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent
us-gaap:LongTermLoansPayable · last filed 2023-11-06
- 2023-09-30: Loans Payable, Noncurrent $34.55M.
- 2023-06-30: Loans Payable, Noncurrent $20.80M.
- 2023-03-31: Loans Payable, Noncurrent $25.20M.
- 2022-12-31: Loans Payable, Noncurrent $33.45M.
| Period end | Loans Payable, Noncurrent |
|---|---|
| 2023-09-30 | $34.55M 10-Q · filed 2023-11-06 |
| 2023-06-30 | $20.80M 10-Q · filed 2023-08-07 |
| 2023-03-31 | $25.20M 10-Q · filed 2023-05-02 |
| 2022-12-31 | $33.45M 10-Q · filed 2023-11-06 |
| 2022-09-30 | $38.67M 10-Q · filed 2022-11-01 |
| 2022-06-30 | $43.82M 10-Q · filed 2022-08-02 |
| 2022-03-31 | $47.68M 10-Q · filed 2022-05-04 |
| 2021-12-31 | $51.55M 10-K · filed 2023-03-31 |
| 2021-09-30 | $32.67M 10-Q · filed 2021-11-02 |
| 2021-06-30 | $34.07M 10-Q · filed 2021-08-03 |
| 2021-03-31 | $34.19M 10-Q · filed 2021-05-04 |
| 2020-12-31 | $34.33M 10-K · filed 2022-03-08 |
| 2020-09-30 | $60.35M 10-Q · filed 2020-11-04 |
| 2020-06-30 | $61.51M 10-Q · filed 2020-08-04 |
| 2020-03-31 | $60.92M 10-Q · filed 2020-05-05 |
| 2019-12-31 | $60.34M 10-K · filed 2021-03-09 |
| 2019-09-30 | $59.77M 10-Q · filed 2019-11-05 |
| 2019-06-30 | $46.88M 10-Q · filed 2019-08-06 |
| 2019-03-31 | $40.74M 10-Q · filed 2019-05-08 |
| 2018-12-31 | $42.60M 10-K · filed 2020-03-11 |
| 2018-09-30 | $44.05M 10-Q · filed 2018-11-06 |
| 2018-06-30 | $45.33M 10-Q · filed 2018-09-04 |
| 2017-12-31 | $45.51M 10-K · filed 2019-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |